Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells

Area of Science:

• Immunology
• Cellular Biology
• Molecular Biology

Background:

• Interleukin-6 (IL-6) production by murine Th2 T cells is linked to humoral immunity regulation.
• Limited data exists on IL-6 production mechanisms in human T cells.

Purpose of the Study:

• To investigate the requirements for IL-6 production by purified human T cells.
• To identify accessory signals that induce IL-6 expression in human T cells.

Main Methods:

• Purified human blood T cells were stimulated with immobilized anti-CD3 monoclonal antibody (mAb).
• Accessory signals including recombinant interleukin-1 beta (rIL-1 beta), other cytokines, phorbol 12-myristate 13-acetate (PMA), and anti-CD28 mAb were tested.
• IL-6 mRNA expression and protein secretion were measured.
• CD28 ligation was achieved using anti-CD28 mAb or its natural ligand B7/BB1.

Main Results:

• Anti-CD3 mAb alone induced IL-2 and TNF-alpha but not IL-6.
• IL-1 beta addition to anti-CD3 stimulation induced IL-6 mRNA and protein secretion in both CD4+ and CD8+ T cells.
• PMA or CD28 ligation served as effective helper signals for IL-6 production.
• Combinations of IL-1 beta with anti-CD28 mAb or PMA with anti-CD28 mAb showed synergistic effects on IL-6 production.

Conclusions:

• T cell receptor triggering alone does not induce IL-6 production in human T cells.
• Interleukin-1 beta, CD28 ligation, and PMA activate distinct intracellular signaling pathways that co-induce IL-6 production.
• Understanding these pathways is crucial for regulating T cell-mediated immune responses.